Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 2/20 | 0.67 |
| ▸ | PKM | P14618 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18821891 | 0.86 | PKM (0.50) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL20395550 | 0.86 | LDHA (0.50) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL491220 | 0.85 | LDHA (0.67) | LDHAKDM4EMAPTPTGS2ALDH1A1 | |
| SCHEMBL491022 | 0.83 | LDHA (0.47) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL20162238 | 0.82 | LDHA (0.50) | LDHAKDM4ETSHRKMT2ACYP3A4 | |
| SCHEMBL20162267 | 0.82 | LDHA (0.46) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL491190 | 0.81 | LDHA (0.76) | LDHAALOX5LMNAGAAPTGS1 | |
| SCHEMBL9654228 | 0.80 | LDHA (0.45) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL490731 | 0.80 | LDHA (1.00) | LDHAPKMCA12CA1CA2 | |
| SCHEMBL624795 | 0.79 | FOS (0.50) | PKMCA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871735-B1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2015-12-23 | — | — | EP | claimed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4007561-B1 | PREVENTION AND REDUCTION OF CORNIFICATION DISORDERS AND RELATED COSMETIC AGENTS | MERCK PATENT GMBH (DE) | 2025-08-27 | — | — | EP | disclosed |
| EP-4486361-A1 | COSMETIC USE OF A COMPOSITION COMPRISING AN AQUEOUS SEAWEED EXTRACT OF PELVETIA CANALICULATA FOR INCREASING GLOSS OF SKIN | Merck Patent GmbH (DE) | 2025-01-08 | — | — | EP | disclosed |
| CN-118632702-A | Cosmetic use of a composition comprising an extract of carrageen aquatic seaweed for increasing skin shine | 默克专利股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| EP-3756642-B1 | METHOD TO INCREASE CELLULAR AVAILABILITY OF CALCIUM IN SKIN CELLS AND MIXTURES | MERCK PATENT GMBH (DE) | 2024-06-26 | — | — | EP | disclosed |
| EP-4301793-A1 | CYANOACRYLATE COMPOSITION WITH HAZARDLESS STABILIZER | H.B. Fuller Company (US) | 2024-01-10 | — | — | EP | disclosed |
| WO-2023161415-A1 | COSMETIC USE OF A COMPOSITION COMPRISING AN AQUEOUS SEAWEED EXTRACT OF PELVETIA CANALICULATA FOR INCREASING GLOSS OF SKIN | MERCK PATENT GMBH (DE) | 2023-08-31 | — | — | WO | disclosed |
| US-11737997-B2 | Method to increase cellular availability of calcium in skin cells and mixtures | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| WO-2022187848-A1 | CYANOACRYLATE COMPOSITION WITH HAZARDLESS STABILIZER | H.B. FULLER COMPANY (US) | 2022-09-09 | — | — | WO | disclosed |
| WO-2008119428-A1 | PHOTOSTABLE COMPOSITIONS | MERCK PATENT GMBH (DE) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008113450-A2 | USE OF CHROMAN-4-ON-DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008110465-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (CH) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008089822-A2 | ANTIMICROBIAL COMPOSITION COMPRISING ZINC OXIDE, BARIUM SULPHATE AND SILVER IONS | MERCK PATENT GMBH (DE) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008071292-A1 | METHOD OF INCREASING THE TANNING EFFECT OF SELF-TANNING SUBSTANCES | MERCK PATENT GMBH (DE) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008052631-A1 | [(4-OXO-4H-CHROMEN-3-YL)-HYDROXY METHYL]- OR [(4-OXO-4H-CHROMEN-3-YL)-METHYL]-PHOSPHONIC ACID DERIVATES | MERCK PATENT GMBH (DE) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008017346-A2 | USE OF ASCORBIC ACID DERIVATIVES FOR THE FUNCTIONALIZATION OF MATRICES | MERCK PATENT GMBH (DE) | 2008-02-14 | — | — | WO | disclosed |
| WO-2007121818-A1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121845-A1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007118565-A1 | USE OF FLAVONOIDS | MERCK PATENT GMBH (DE) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737997-B2 | Method to increase cellular availability of calcium in skin cells and mixtures | CA2, CHERP, SLC8B1 | LDHA 1856/4885PKM 2041/4885CA12 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.